MBX Biosciences, Inc.（MBX）内部人交易：高管与董事近期交易
过去 18 个月，共有 10 位内部人为 MBX Biosciences, Inc.（MBX）报告了 23 笔 Form 4 交易（最近一笔 2026-08-05）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-05 | Azoulay Salomon | Chief Medical Officer | 卖出 | 370 | $24,335 |
| 2026-08-04 | Hoerter Steven L. | President and CEO | 买入 | 71,000 | $0 |
| 2026-08-04 | Smither John W | Chief Financial Officer | 买入 | 28,000 | $0 |
| 2026-05-11 | Azoulay Salomon | Chief Medical Officer | 买入 | 55,000 | $575,300 |
| 2026-05-11 | Azoulay Salomon | Chief Medical Officer | 卖出 | 55,000 | $2.1M |
| 2026-05-11 | Azoulay Salomon | Chief Medical Officer | 买入 | 15,003 | $240,048 |
| 2026-05-11 | Azoulay Salomon | Chief Medical Officer | 卖出 | 15,003 | $574,615 |
| 2026-05-08 | Hawryluk P. Kent | President & CEO | 卖出 | 607 | $17,931 |
| 2026-05-08 | Azoulay Salomon | Chief Medical Officer | 卖出 | 231 | $6,824 |
| 2026-05-04 | Hoerter Steven L. | 董事 | 买入 | 11,938 | $0 |
| 2026-03-16 | Hawryluk P. Kent | President & CEO | 买入 | 18,500 | $525,585 |
| 2026-02-27 | Hawryluk P. Kent | President & CEO | 买入 | 28,768 | $460,288 |
| 2026-02-03 | Bartram Richard | Chief Financial Officer | 买入 | 15,000 | $0 |
| 2026-02-03 | Hawryluk P. Kent | President & CEO | 买入 | 35,250 | $0 |
| 2026-02-03 | Azoulay Salomon | Chief Medical Officer | 买入 | 15,000 | $0 |
| 2025-10-28 | Hawryluk P. Kent | President & CEO | 买入 | 182,859 | $594,292 |
| 2025-10-21 | Hawryluk P. Kent | President & CEO | 买入 | 20,000 | $272,800 |
| 2025-10-20 | Hoerter Steven L. | 董事 | 买入 | 20,000 | $265,000 |
| 2025-09-30 | Topper James N | 10% 以上股东 | 买入 | 666,666 | $12.0M |
| 2025-09-30 | Heron Patrick J | 董事 | 买入 | 666,666 | $12.0M |
| 2025-09-30 | FHMLS X, L.L.C. | 10% 以上股东 | 买入 | 666,666 | $12.0M |
| 2025-09-30 | Frazier Life Sciences X, L.P. | 10% 以上股东 | 买入 | 666,666 | $12.0M |
| 2025-09-30 | FHMLS X, L.P. | 10% 以上股东 | 买入 | 666,666 | $12.0M |
来源：SEC Form 4 申报文件 · 截至 2026-08-05